Volastra Therapeutics Company
Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers.
Technology:
Tumor-Specific Antigens
Industry:
Tumor-Specific Antigens
Headquarters:
New York, New York, United States
Founded Date:
2019-01-01
Employees Number:
51-100
Funding Status:
Seed
Investors Number:
12
Total Funding:
44000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-04-06
Last Funding Type:
Seed
Register and Claim Ownership